Market Highlights Antihelminthics are prescribed to kill parasites (helminthes). Common parasitic infestations include amebiasis, malaria, giardiasis, hookworm, pinworm, threadworm, whipworm and tapeworm infestations. The drugs function either by destroying the worms on contact or by paralyzing them, or by altering the permeability of their plasma membranes. According to World Health Organization (2014), over 1.5 billion people are infected with soil-transmitted helminths worldwide. Additionally, According to the latest report published by WHO, more than 880 million children are in need of treatment for these parasitic diseases. Increasing prevalence of parasitic diseases, rising demand for the treatment, and increasing number of patients drives the growth of the market. Moreover, changing lifestyle and increasing geriatric population have increased the probability of causing digestive tract infections, thus helps in driving the growth of the market. Additionally, the increasing need for the cost-effective treatment and increasing per capita income have fuelled the market growth. However, antihelminthics drugs are slightly toxic and some of the side effects are observed in some patients. This factors may restrain the growth of the market. The global antihelminthics market is expected to grow at a CAGR of ~ 5.3% during the forecast period 2017-2023. Antihelminthics are a group of antiparasitic drugs that are prescribed to kill parasites (helminthes) in common parasitic infestations such as fasciolasis, filariasis, angiostrongylosis, and others. The global Antihelminthic Drugs Market Size is likely to capture a CAGR of 5.3% and reach high growth figures over the forecast period of 2017-2027, projects Market Research Future (MRFR) in an exclusive study. Parasitic diseases such as schistosomiasis, whipworm infection, ascariasis, and other intestinal infections are most prevalent in East Asia, sub-Saharan Africa, and India. Parasitic diseases occur in unhygienic conditions in the developing countries where a majority of the population suffering from such diseases induce high demand for antihelminthics and boost the growth of the global antihelminthics market. In the last few years, extensive research programs have been initiated which has resulted in thedevelopment and modification of existing drugs. The pharmaceuticalindustry has been able to produce a wide spectrum of highly effective antihelminthics which has been a plus for the growth of the global antihelminthics market. Other factors spurring the growth of the global anthelminthic market include growing geriatric population and rapidly expanding healthcare sector, especially in developing economies. On the other hand, the growth of the global antihelminthics market might be impeded by the side effects associated with antihelminthics. Also, overuse of antihelminthics leads to the emergence of resistant microbes which might affect the efficacy of antihelminthics. READ MORE @ https://www.marketresearchfuture.com/reports/antihelminthics-market-4500 Browse More Related Reports at: Orthopedic Braces Market Research Report - Global Forecast till 2027 Clinical Trials Market Research Report - Forecast to 2027 Digital Diabetes Management Market Research Report – Global Forecast till 2027 Competitive Landscape: Sanofi (US),Merck & Co., Inc. (US),GlaxoSmithKline Plc. (US),AstraZeneca (UK),Bayer AG (Germany),Sanofi (France),ALLERGAN (Ireland),Mentis Pharma Ltd. (India),Abbott (US),ZEISS International (Germany),AstellasPharma Inc. (Japan),Johnson & Johnson Services, Inc. (US),Novartis AG (Switzerland), and Pfizer Inc. (US).